The role of bile acids and their TGR5 receptor in irritable bowel syndrome and diarrhoea

This commentary looks at recent findings relating to bile acids in patients with irritable bowel syndrome with diarrhoea (IBS-D). Bile acid diarrhoea is recognised to be a frequent, treatable cause of chronic diarrhoea, with a clinical picture which overlaps IBS-D. In the study - by Wei and colleagues, a large proportion of IBS-D patients were shown to have increased faecal bile acids, and an increase in primary bile acids, reflecting changes in bacterial metabolism. Expression of the colonic membrane bile acid receptor, TGR5, was associated with faecal bile acids and the severity of symptoms. (C) 2021 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Automated summary

Recent findings suggest that a large proportion of IBS-D patients have increased faecal bile acids, including primary bile acids, indicating changes in bacterial metabolism. The expression of the colonic membrane bile acid receptor TGR5 is associated with faecal bile acids and the severity of symptoms.